Current Trends and Future Directions of Malignancy After kidney Transplantation: A 1970-2022 Bibliometric Analysis
CONCLUSIONS The focus of MKT-related studies has evolved from exploring the spectrum, risk factors, and outcomes of MKT, to examining the pathogenesis, individualized screening, prevention, and treatment, including appropriate use of immune checkpoint inhibitors. Reports of renal transplant recipients infected with SARS-CoV-2 or COVID-19 have also gained attention since 2019. These suggest that individualized management remains a frontier for research and a future direction in MKT topics.PMID:38163947 | PMC:PMC10771012 | DOI:10.12659/AOT.942074
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Fan Jiang Fang Wang Tianyu Zhang Hongmei Dong Hongwei Bai Liping Chen Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Covid Vaccine | COVID-19 | Kidney Cancer | Kidney Transplant | Kidney Transplantation | Renal Cell Carcinoma | SARS | Science | Skin | Skin Cancer | Squamous Cell Carcinoma | Study | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines | Yervoy